Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $505.75 | Total: $2,528.75 |
| 1 | 10 | $428.40 | Total: $4,284.00 |
| 1 | 25 | $362.95 | Total: $9,073.75 |
| 1 | 50 | $309.40 | Total: $15,470.00 |
| 1 | 100 | $267.75 | Total: $26,775.01 |
Overview
VEGFR-2-IN-9 (KDR-in-4) is a potent KDRVEGFR2 inhibitor with an IC50 of 7 nM, suitable for breast cancer research.
Chemical Properties
| Molecular Formula | C23H25N3O3 |
| Molecular Weight | 391.46 |
| CAS Numbers | 408502-06-7 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | O=C1NC=2C=CC=CC2C=C1C3=CC4=CC(OCCN(C)CCOC)=CC=C4N3 |
Storage and Handling
0C Short Term, -20C Long Term
References
Kinose F, et al. Inhibition of retinal and choroidal neovascularization by a novel KDR kinase inhibitor. Molecular Vision 2005; 11 366-373